national formulary listing process
TRANSCRIPT
-
8/3/2019 National Formulary Listing Process
1/14
National Formulary
Listing Process
i) Hospital Meeting
ii) State Meeting
iii) National Meetingiv) Hospital Drug Utilization meeting
v) First LPO
vi) Subsequent LPO
vii) Tender
-
8/3/2019 National Formulary Listing Process
2/14
What is Blue Book?
MOH Drug Formulary contains a list of drugs
approved for use in all hospitals/institutions in the
MOH. The Formulary is to promote rational, costeffective use of drugs whereby newer and effective
drugs were introduced in a manner so as to
minimize wastages and funds set aside for the
purchase of drugs, are optimally used.
-
8/3/2019 National Formulary Listing Process
3/14
Proforma
A - Proposal to delete any of the drug/dosage
form/formulation in the MOH drug Formulary
B - Proposal to alter/add formulation/dosageform/category of the prescriber/ indication in the
MOH Drug Formulary
D- Proposal to introduce new drugs into the MOH
Drug Formulary
** proforma ( forms )
-
8/3/2019 National Formulary Listing Process
4/14
Category of Prescriber
A* Consultants/Specialists for specific indications
only
A Consultant/Specialists
A/KK Consultant/Specialists/Family Physician
Specialists
B Medical OfficersC Paramedics
-
8/3/2019 National Formulary Listing Process
5/14
Hospital Drug Committee members
Hospital Director- Chairman
Chief Pharmacist- Secretary
SeniorConsultants from Paeds, O&G, Surgical and
Medical
Other specialists and DIP
-
8/3/2019 National Formulary Listing Process
6/14
State Drug Committee members
State Health Director - Chairman
Deputy State Health Directors (4) ie Medical, Public
Health, Dental and Pharmacy
SeniorConsultants in State ie Medical,Surgical,O&G and Paeds
FMS
Ch
ief Pharmacist
Senior pharmacist
** Quorum for meeting 6 pax
-
8/3/2019 National Formulary Listing Process
7/14
Sub-comm Anti-infectives
Neuro/neurosurgeri
ENT
Psychiatry
Gastro
Respiratory
Cardiovascular Oncology
Rheumatology and Immunology
Dermatology
Anaesthesiology
Paediatric
O&G Endocrine
Opthamology
Urology and Nefrology
Transplan
** Quorum for meeting at least 4
-
8/3/2019 National Formulary Listing Process
8/14
Drug Utilization Meeting
Objective:
1) To make new approved drugs available, in the
respective hospitals
2) To increase quota for number of patients
-
8/3/2019 National Formulary Listing Process
9/14
First LPO
Follow up closely with the Drug Info Pharmacists on the
outcome of the Drug Utilization meeting,or
Get meeting outcome from the a) initiator, b) HODs c)
purchasing pharmacist
Once confirmed, get the pharmacist to put in the 1st LPO
If the purchase is less than RM 50K, usually one bumi agent
to quote
-
8/3/2019 National Formulary Listing Process
10/14
Subsequent LPOs
Once the drug has reached the RM 50K purchase,
pharmacists have to put up the Lampiran Q requests.
Lampiran Q is the request form to purchase up to RM 500K
Lampiran Q is a form to be filled up by store pharmacists,
approved by Chief Pharmacists then passed on to Pengarah
Hospital for approval
Once Pengarah Hospital approves , it will be passed on to
the Store pharmacists for subsequent purchase
If the drug reaches RM 500K, then pharmacists can request
to Tender Division, Bahagian Farmasi, Petaling Jaya to
extend to tender status
-
8/3/2019 National Formulary Listing Process
11/14
Tender
Usually when a drug reaches RM 500K, and it is not the end of the year
yet, the pharmacists can write in a request letter to the Bahagian Farmasi,
to request to expedite the tender request.
Normal way,Bah
agian Farmasi will compile th
e list from allh
ospitals andthen the top 20 drugs will be chosen as tender drugs
Specification of these drugs are done by the pharmacists in charge of
tender in Bahagian Farmasi, Petaling Jaya
After specifications are decided, it will be sent to Bahagian Perolehan dan
Penswastaan, MOH in Putrajaya for the calling of tender
Tenders are then called for and advertise in papers
-
8/3/2019 National Formulary Listing Process
12/14
Bumi agents interested in participating, will buy the tender documents from Bhg Perolehandan Penswastaan counter ( RM 50/tender document)
Bumi agents will then request from the Principal Pharma company, to participate in the
tender, to quote the price through them
Pharma company will then submit price through the chosen bumi agents
Bumi agents will submit the tender documents to the Bhg Perolehan dan Penswastaan,
before th
e closing date After the closing date, Bhg Perolehan will open the documents and compile according to
drugs and number of agents participating for each drug ( pricing revealed)
Afterwhich, these drugs go through a technical committee meeting , which comprises of
i) the tender division pharmacists from Bahagian Farmasi,
ii) Consultants from the respective therapeutics , usually from Klang Valley
After th
e tech
nical committeehas decided, t
he files will be sent to Ba
hagian Perole
han danPenswastaan where the division will then go through the files
Then it will be sent to the Board of Directors in MOH for approval. Decision is based on both
tender specifications and price .
Tender value less than RM 50M, Ketua Setiausaha of MOH approves
Tender more than RM 50M, goes to MOF to be signed ( tender board A)
-
8/3/2019 National Formulary Listing Process
13/14
If the tender is supplied throughCIF then, it has to go through another process of
clearance from the Treasury Department, MOF. Then sent to MITI to request for
import permit
Those supplied through FOB, will then sent to MITI to request for import permit.
This is only for drugs that is imported. For drugs manufactured in Malaysia, do not
have to go through MITI After receiving the import permit from MITI, Bahagian Perolehan will send letter of
award to the respective bumi agents that have succeeded in the tender
participation
Bumi agents inform the respective Pharma company and also we have to ensure
that bumi agents fax a copy of the letter of award to all hospital pharmacists
** Time taken from the technical committee meets to tender awarded differs fromCIF to FOB.
CIF takes longer as it needs treasury approval, ie 4-5 months
FOB takes 2 months
-
8/3/2019 National Formulary Listing Process
14/14
Hospital
meetingState
MeetingBB
Meeting
Drug
Utilization
Meeting
First LPO
Lampiran
Q
Usage to
RM
500K
Hospital
request for
tender status